[Immunobiology of chronic inflammatory bowel diseases].
Siegmund
B
B
Medizinische Klinik I, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin. britta.siegmund@charite.de
Zeitz
M
M
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000941:Antigens / Q000276:immunology*; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D006801:Humans; D018928:Immunity, Mucosal; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D000069285:Infliximab; D007413:Intestinal Mucosa / Q000276:immunology; D009154:Mutation; D019936:Probiotics; D015398:Signal Transduction
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000941:Antigens; D005765:Gastrointestinal Agents; D000069285:Infliximab